Benefiting from aging of population, consumption upgrade and policy support, China's orthopaedic instrument business has seen speedy development over the years, with total market size rising from three.28 billion yuan in 2006 to nine.85 billion yuan in 2012.
Trauma product, spine product and joint product represent the 3 major market segments of Chinese orthopaedic instrument business. In 2012, the 3 principal product accounted for Associate in Nursing combination market share of regarding eighty two.2%, of which, trauma product showed the best, or so thirty five.5%, with market scrutinise eighteen.24% YoY; spine and joint product hierarchal second (up twelve.6% YoY) and third (up twelve.4% YoY), severally.
Browse Full Report with TOC @ : http://www.marketresearchreports.biz/analysis-details/china-orthopedic-instrument-industry-report-2013-2015
In recent years, in conjunction with the increasing investment of foreign-funded enterprises in China, the trend of foreign monopoly has been additional evident. once the acquisition of Synthes in 2012, Johnson & Johnson has became the most important company in China's orthopaedic instrument market, with market share of each trauma and spine product occupying the primary place.
In November 2012, Medtronic purchased KangHui Medical for $816 million, therefore creating a vital step in Chinese orthopaedic instrument market localization. Compared with Medtronic's high-end positioning, reasonable KangHui product will facilitate Medtronic expand low- and medium-end markets in rising countries and regions (including China). In 2012, Medtronic (including KangHui Medical) occupied fifteen.9% of China's spine market.
Stryker may be a world-renowned orthopaedic instrument enterprise, and its joint product account for regarding 2 hundredth of world market share. In Gregorian calendar month 2013, Stryker noninheritable Trauson Holdings for $764 million, and in virtue of the latter’s R&D and producing capability and distribution network blessings more expanded its market share in China, expected to occupy 8%-10% of China's orthopaedic market in 2013.
Relying on powerful R&D strength and mature distribution network, Weigao has already become the most important native provider of orthopaedic devices in China. In 2012, its orthopaedic device business achieved revenue of 223 million yuan, and trauma instrumentality product occupied market share of five.1% or so.
In future, the Chinese orthopaedic instrument market can encounter additional fierce competition, within which tiny firms attributable to low R&D level, deficient production capability and non-standard internal control tend to be step by step eliminated, and therefore the market are going to be more targeted in business magnates with excellent monetary and technical strength.
China orthopaedic Instrument business Report, 2013-2015 of ResearchInChina chiefly covers the followings:
Overview, market structure and development prospect, etc. of world orthopaedic instrument industry;
Market structure, competition pattern, barriers to entry, import & export, etc. of China orthopaedic instrument industry;
Development setting (including policy setting, development prospects likewise as development of upstream and downstream industries) for China orthopaedic instrument industry; Operating conditions, etc. of twelve orthopaedic instrument firms (including Johnson & Johnson, Medtronic, Stryker, Weigao, Shanghai Kinetic, Peiping AKEC Medical, United orthopaedic Corporation, etc.) in China.
Click here to download detail report : http://www.marketresearchreports.biz/sample/sample/174491
Table of Content
1. summary of orthopaedic Instrument business
1.1 Definition
1.2 Classification
1.3 business Chain
2. Development of world orthopaedic Instrument business
2.1 Overview
2.2 Development Prospect
3. Development of China orthopaedic Instrument business
3.1 Overview
3.2 Market Structure
3.3 Import & Export
3.3.1 Import
3.3.2 Export
3.4 Competition Pattern
3.5 Barriers to Entry
3.5.1 Technology
3.5.2 Market Access
3.5.3 Sales Channel
3.5.4 Talent
3.6 Sales Model
4. Development setting for China orthopaedic Instrument business
4.1 Policy setting
4.1.1 restrictive Policy
4.1.2 business Policy
4.2 Upstream and Downstream Industries
4.2.1 Upstream
4.2.2 Downstream
4.3 Development Prospects
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Sales : sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog @ : http://marketresearchreportsbiz1.wordpress.com/
Trauma product, spine product and joint product represent the 3 major market segments of Chinese orthopaedic instrument business. In 2012, the 3 principal product accounted for Associate in Nursing combination market share of regarding eighty two.2%, of which, trauma product showed the best, or so thirty five.5%, with market scrutinise eighteen.24% YoY; spine and joint product hierarchal second (up twelve.6% YoY) and third (up twelve.4% YoY), severally.
Browse Full Report with TOC @ : http://www.marketresearchreports.biz/analysis-details/china-orthopedic-instrument-industry-report-2013-2015
In recent years, in conjunction with the increasing investment of foreign-funded enterprises in China, the trend of foreign monopoly has been additional evident. once the acquisition of Synthes in 2012, Johnson & Johnson has became the most important company in China's orthopaedic instrument market, with market share of each trauma and spine product occupying the primary place.
In November 2012, Medtronic purchased KangHui Medical for $816 million, therefore creating a vital step in Chinese orthopaedic instrument market localization. Compared with Medtronic's high-end positioning, reasonable KangHui product will facilitate Medtronic expand low- and medium-end markets in rising countries and regions (including China). In 2012, Medtronic (including KangHui Medical) occupied fifteen.9% of China's spine market.
Stryker may be a world-renowned orthopaedic instrument enterprise, and its joint product account for regarding 2 hundredth of world market share. In Gregorian calendar month 2013, Stryker noninheritable Trauson Holdings for $764 million, and in virtue of the latter’s R&D and producing capability and distribution network blessings more expanded its market share in China, expected to occupy 8%-10% of China's orthopaedic market in 2013.
Relying on powerful R&D strength and mature distribution network, Weigao has already become the most important native provider of orthopaedic devices in China. In 2012, its orthopaedic device business achieved revenue of 223 million yuan, and trauma instrumentality product occupied market share of five.1% or so.
In future, the Chinese orthopaedic instrument market can encounter additional fierce competition, within which tiny firms attributable to low R&D level, deficient production capability and non-standard internal control tend to be step by step eliminated, and therefore the market are going to be more targeted in business magnates with excellent monetary and technical strength.
China orthopaedic Instrument business Report, 2013-2015 of ResearchInChina chiefly covers the followings:
Overview, market structure and development prospect, etc. of world orthopaedic instrument industry;
Market structure, competition pattern, barriers to entry, import & export, etc. of China orthopaedic instrument industry;
Development setting (including policy setting, development prospects likewise as development of upstream and downstream industries) for China orthopaedic instrument industry; Operating conditions, etc. of twelve orthopaedic instrument firms (including Johnson & Johnson, Medtronic, Stryker, Weigao, Shanghai Kinetic, Peiping AKEC Medical, United orthopaedic Corporation, etc.) in China.
Click here to download detail report : http://www.marketresearchreports.biz/sample/sample/174491
Table of Content
1. summary of orthopaedic Instrument business
1.1 Definition
1.2 Classification
1.3 business Chain
2. Development of world orthopaedic Instrument business
2.1 Overview
2.2 Development Prospect
3. Development of China orthopaedic Instrument business
3.1 Overview
3.2 Market Structure
3.3 Import & Export
3.3.1 Import
3.3.2 Export
3.4 Competition Pattern
3.5 Barriers to Entry
3.5.1 Technology
3.5.2 Market Access
3.5.3 Sales Channel
3.5.4 Talent
3.6 Sales Model
4. Development setting for China orthopaedic Instrument business
4.1 Policy setting
4.1.1 restrictive Policy
4.1.2 business Policy
4.2 Upstream and Downstream Industries
4.2.1 Upstream
4.2.2 Downstream
4.3 Development Prospects
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Sales : sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog @ : http://marketresearchreportsbiz1.wordpress.com/
0 comments:
Post a Comment